Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health.
Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Viveros-Ruiz TL, Almeda-Valdes P, Gomez-Velasco D, Mehta R, Elias-López D, Cruz-Bautista I, Roldán-Valadez E, Martagón AJ, Aguilar-Salinas CA. Bello-Chavolla OY, et al. Clin Nutr. 2020 May;39(5):1613-1621. doi: 10.1016/j.clnu.2019.07.012. Epub 2019 Jul 30. Clin Nutr. 2020. PMID: 31400997
Elevated serum uric acid is a facilitating mechanism for insulin resistance mediated accumulation of visceral adipose tissue.
Fernández-Chirino L, Antonio-Villa NE, Fermín-Martínez CA, Márquez-Salinas A, Guerra EC, Vargas-Vázquez A, Almeda-Valdés P, Gómez-Velasco D, Viveros-Ruiz TL, Rojas R, Aguilar Salinas CA, Bello-Chavolla OY. Fernández-Chirino L, et al. Among authors: gomez velasco d. Clin Endocrinol (Oxf). 2022 May;96(5):707-718. doi: 10.1111/cen.14673. Epub 2022 Jan 9. Clin Endocrinol (Oxf). 2022. PMID: 35001416
METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.
Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, Sánchez-Lázaro D, Meza-Oviedo D, Vargas-Vázquez A, Campos OA, Sevilla-González MDR, Martagón AJ, Hernández LM, Mehta R, Caballeros-Barragán CR, Aguilar-Salinas CA. Bello-Chavolla OY, et al. Eur J Endocrinol. 2018 May;178(5):533-544. doi: 10.1530/EJE-17-0883. Epub 2018 Mar 13. Eur J Endocrinol. 2018. PMID: 29535168
Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia.
Cruz-Bautista I, Huerta-Chagoya A, Moreno-Macías H, Rodríguez-Guillén R, Ordóñez-Sánchez ML, Segura-Kato Y, Mehta R, Almeda-Valdés P, Gómez-Munguía L, Ruiz-De Chávez X, Rosas-Flota X, Andrade-Amado A, Bernal-Barroeta B, López-Carrasco MG, Guillén-Pineda LE, López-Estrada A, Elías-López D, Martagón-Rosado AJ, Gómez-Velasco D, Lam-Chung CE, Bello-Chavolla OY, Del Razo-Olvera F, Cetina-Pérez LD, Acosta-Rodríguez JL, Tusié-Luna MT, Aguilar-Salinas CA. Cruz-Bautista I, et al. Lipids Health Dis. 2021 Feb 15;20(1):14. doi: 10.1186/s12944-021-01436-6. Lipids Health Dis. 2021. PMID: 33588820 Free PMC article.
Evaluation of a Web Platform to Record Lifestyle Habits in Subjects at Risk of Developing Type 2 Diabetes in a Middle-Income Population: Prospective Interventional Study.
Sevilla-Gonzalez MDR, Bourguet-Ramirez B, Lazaro-Carrera LS, Martagon-Rosado AJ, Gomez-Velasco DV, Viveros-Ruiz TL. Sevilla-Gonzalez MDR, et al. Among authors: gomez velasco dv. JMIR Diabetes. 2022 Jan 17;7(1):e25105. doi: 10.2196/25105. JMIR Diabetes. 2022. PMID: 35037888 Free PMC article.
Primary Barriers of Adherence to a Structured Nutritional Intervention in Patients with Dyslipidemia.
Del Razo-Olvera FM, Martin-Vences AJ, Brito-Córdova GX, Elías-López D, Landa-Anell MV, Melgarejo-Hernández MA, Cruz-Bautista I, Manjarrez-Martínez I, Gómez-Velasco DV, Aguilar-Salinas CA. Del Razo-Olvera FM, et al. Among authors: gomez velasco dv. Nutrients. 2021 May 21;13(6):1744. doi: 10.3390/nu13061744. Nutrients. 2021. PMID: 34063795 Free PMC article.
Contribution of Known Genetic Risk Variants to Dyslipidemias and Type 2 Diabetes in Mexico: A Population-Based Nationwide Study.
Huerta-Chagoya A, Moreno-Macías H, Sevilla-González M, Rodríguez-Guillén R, Ordóñez-Sánchez ML, Gómez-Velasco D, Muñóz-Hernández L, Segura-Kato Y, Arellano-Campos O, Cruz-Bautista I, Aguilar-Salinas CA, Tusié-Luna T. Huerta-Chagoya A, et al. Genes (Basel). 2020 Jan 20;11(1):114. doi: 10.3390/genes11010114. Genes (Basel). 2020. PMID: 31968565 Free PMC article. Clinical Trial.
A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes.
Mercader JM, Liao RG, Bell AD, Dymek Z, Estrada K, Tukiainen T, Huerta-Chagoya A, Moreno-Macías H, Jablonski KA, Hanson RL, Walford GA, Moran I, Chen L, Agarwala V, Ordoñez-Sánchez ML, Rodríguez-Guillen R, Rodríguez-Torres M, Segura-Kato Y, García-Ortiz H, Centeno-Cruz F, Barajas-Olmos F, Caulkins L, Puppala S, Fontanillas P, Williams AL, Bonàs-Guarch S, Hartl C, Ripke S; Diabetes Prevention Program Research Group; Tooley K, Lane J, Zerrweck C, Martínez-Hernández A, Córdova EJ, Mendoza-Caamal E, Contreras-Cubas C, González-Villalpando ME, Cruz-Bautista I, Muñoz-Hernández L, Gómez-Velasco D, Alvirde U, Henderson BE, Wilkens LR, Le Marchand L, Arellano-Campos O, Riba L, Harden M; Broad Genomics Platform; Gabriel S; T2D-GENES Consortium; Abboud HE, Cortes ML, Revilla-Monsalve C, Islas-Andrade S, Soberon X, Curran JE, Jenkinson CP, DeFronzo RA, Lehman DM, Hanis CL, Bell GI, Boehnke M, Blangero J, Duggirala R, Saxena R, MacArthur D, Ferrer J, McCarroll SA, Torrents D, Knowler WC, Baier LJ, Burtt N, González-Villalpando C, Haiman CA, Aguilar-Salinas CA, Tusié-Luna T, Flannick J, Jacobs SBR, Orozco L, Altshuler D, Florez JC; SIGMA T2D Genetics Consortium. Mercader JM, et al. Diabetes. 2017 Nov;66(11):2903-2914. doi: 10.2337/db17-0187. Epub 2017 Aug 24. Diabetes. 2017. PMID: 28838971 Free PMC article.
29 results